Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H14F2N3O13P3 |
Molecular Weight | 503.1379 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C2(F)F
InChI
InChIKey=YMOXEIOKAJSRQX-QPPQHZFASA-N
InChI=1S/C9H14F2N3O13P3/c10-9(11)6(15)4(25-7(9)14-2-1-5(12)13-8(14)16)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,4,6-7,15H,3H2,(H,20,21)(H,22,23)(H2,12,13,16)(H2,17,18,19)/t4-,6-,7-/m1/s1
Molecular Formula | C9H14F2N3O13P3 |
Molecular Weight | 503.1379 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase. | 2003 Jan |
|
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors. | 2006 May |
|
Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy. | 2008 Mar |
|
In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells. | 2010 Aug 19 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:33:17 GMT 2023
by
admin
on
Sat Dec 16 09:33:17 GMT 2023
|
Record UNII |
A0Q7SO4OZE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80911928
Created by
admin on Sat Dec 16 09:33:17 GMT 2023 , Edited by admin on Sat Dec 16 09:33:17 GMT 2023
|
PRIMARY | |||
|
110988-86-8
Created by
admin on Sat Dec 16 09:33:17 GMT 2023 , Edited by admin on Sat Dec 16 09:33:17 GMT 2023
|
PRIMARY | |||
|
A0Q7SO4OZE
Created by
admin on Sat Dec 16 09:33:17 GMT 2023 , Edited by admin on Sat Dec 16 09:33:17 GMT 2023
|
PRIMARY | |||
|
130659
Created by
admin on Sat Dec 16 09:33:17 GMT 2023 , Edited by admin on Sat Dec 16 09:33:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|